Navigation Links
Grupo Casa Saba Announces Third Quarter 2007 Results
Date:10/26/2007

Operating Income and Operating Income plus Depreciation and Amortization

Increased 2.96% and 4.71%, Respectively

MEXICO CITY, Oct. 26 /PRNewswire-FirstCall/ -- Grupo Casa Saba ("Saba", "GCS", "the Company" or "the Group"), one of the leading Mexican distributors of pharmaceutical products, beauty aids, personal care and consumer goods, general merchandise, publications and other products announced today its consolidated financial and operating results for the third quarter of 2007.

(All figures are expressed in millions of pesos as of September 30, 2007. Comparisons are made with the same period of 2006, unless otherwise stated. Figures may vary due to rounding practices. "bp" stands for basis points.)

Financial Highlights:

- Sales in the quarter amounted to $5,821.95 million

- Gross income rose 1.70%

- Gross margin in the quarter was 9.27%

- Operating expenses in the quarter increased by 0.93%

- Operating income increased by 2.96%

- Operating margin was 3.56%

- Net income was $184.21 million, an increase of 13.57%

- Cash and cash equivalents at the end of the period was $368.34 million

QUARTERLY RESULTS

NET SALES

In the third quarter of 2007, GCS sales totaled $5,821.95 million, an increase of 0.33%.

Our divisions of Government Pharma and Health, Beauty, Consumer Goods, General Merchandise and Others grew by 7.15% and 2.98%, respectively, versus the third quarter of 2006. The growth in Health, Beauty, Consumer Goods, General Merchandise and Others division was due to greater volume sales, which offset a lower average unit price. In the case of the Government Pharma division, the increase in sales reflects a higher participation in bidding processes during the quarter.

Publications sales declined 1.53% due to lower prices, despite the fact that the number of items sold increased 10.10%. Sales in the Private Pharma division decreased marginally, by 0.13%, as a result of the competitive environment that GCS faced in the market.

The sales mix was not altered significantly. Private Pharma sales represented 83.27% of total sales, Government Pharma accounted for 3.46%, Health, Beauty, Consumer Goods, General Merchandise and Others totaled 9.33% and Publications the remaining 3.94%.

SALES BY DIVISION:

PRIVATE PHARMA

Sales in the Private Pharma division declined marginally, by 0.13%, as a result of the competitive environment that GCS faced in the marketplace, which had an unfavorable impact on the number of items sold during the quarter. Sales reached $4,847.80 million, representing 83.27% of the Group's total sales.

GOVERNMENT PHARMA

Sales of Government Pharma rose 7.15% to reach $201.63 million. This was mainly due to a higher participation in bidding processes during the quarter.

As a result, Government Pharma increased its participation with respect to total sales, from 3.24% in 3Q06 to 3.46% this quarter.

HEALTH, BEAUTY, CONSUMER GOODS, GENERAL MERCHANDISE AND OTHER

Sales in this division totaled $543.26 million during the quarter, an increase of 2.98% compared to 3Q06. The growth in this division was due to higher sales volume, which offset the decline in average unit prices during the period.

PUBLICATIONS

Citem's sales decreased 1.53% as a result of a lower average price and despite the fact that the number of items sold during the period increased approximately 10.10%.

Publications sales as a percentage of total sales declined from 4.01% in 3Q06 to 3.94% in the third quarter of 2007.

GROSS INCOME

During the third quarter of the year, Grupo Casa Saba's gross income grew 1.70% to reach $539.76 million. Despite the highly competitive environment that has been discussed in previous reports, the Company was able to increase its gross margin to 9.27% during the third quarter of 2007, which compares favorably to the margin of 9.15% registered during the same period of 2006.

OPERATING EXPENSES

The Company's operating expenses rose marginally, by 0.93%, due to the 2.47% increase in sales expenses. Operating expenses as a percentage of sales grew from 5.67% in the third quarter of 2006 to 5.71% in 3Q07. However, Grupo Casa Saba continued to implement cost reduction programs and, as a result, was able to lower its administrative expenses.

OPERATING INCOME

Operating income grew by 2.96% to reach $207.40 million pesos. The operating margin was 3.56%, which is 9 b.p. higher than the margin that was registered during the same quarter of 2006.

OPERATING INCOME PLUS DEPRECIATION AND AMORTIZATION

Operating income plus depreciation and amortization for 3Q07 was $235.72 million, increasing 4.71% from the same period of the previous year. Depreciation for the quarter totaled $28.32 million, an increase of 19.60%.

CASH AND CASH EQUIVALENTS

Cash and cash equivalents at the end of the third quarter of 2007 reached $368.34 million. The reduction in cash was due to higher working capital expenditures.

COMPREHENSIVE COST OF FINANCING

During the third quarter of 2007, GCS's comprehensive cost of financing of $13.33 million was higher than the $3.79 million of 3Q06, as a result of lower interest income.

OTHER EXPENSES (INCOME)

During the third quarter of 2007, the Company registered an income of $72.70 million in other expenses (income). This amount reflects the recovery of taxes from past periods.

It is worth noting that expenses (income) from this line item reflect activities that are distinct from the company's everyday business operations.

TAX PROVISIONS

During the third quarter of 2007, tax provisions rose to $82.56 million. This increase was primarily the result of a reduction in deferred income taxes, related to the recovery of taxes from past periods.

NET INCOME

GCS's net income during the third quarter of 2007 was $184.21 million, an increase of 13.57% versus the $162.19 million from 3Q06. The net margin for the period was 3.16%, which compares favorably to the 2.80% posted during the same period of 2006.

WORKING CAPITAL

During the quarter, the Group's accounts receivable and inventory days increased by 3.8 and 6.1 days compared to 3Q06, to reach 62.1 and 57.4 days, respectively. Our accounts payable days also increased slightly, by 0.8 days, compared to 3Q06. Accounts payable days for the period were 48 days.

Contacts:

GRUPO CASA SABA IR Communications:

Rodrigo Echagaray, IRO Jesus Martinez Rojas

+52 (55) 5284-6672 +52 (55) 5644-1247

rechagar@casasaba.com jesus@irandpr.com

Alejandro Sadurni, CFO

asadurni@casasaba.com


'/>"/>
SOURCE Grupo Casa Saba, S.A.B. de C.V.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
Breaking Medicine Technology: